Introduction
In recent years there has been increasing awareness of the multiple endocrine adenomatosis (MEA) syndromes. In (Adams et al., 1965; Peters et al., 1966 The only new abnormality found was in patient III2 whose serum calcium was 2-7 mmol/l (10-8 mg/100 ml), albumin 46 g/l, phosphate 0 99 mmol/l (3-06 mg/ 100 ml), parathyroid hormone 2 ng/ml (normal range, < 0 9 mg/ml) and calcitonin 0-32 ,ug/l (normal range, < 0-1 ,ug/1).
Discussion MEA Type I is inherited through an autosomal dominant gene with incomplete penetrance, and endocrine dysfunction can be variable with single or multiple involvement in any one family and at any age. The most frequent presenting feature is hypercalcaemia. In a recent series of 119 cases of primary hyperparathyroidism evidence of MEA was found in 17*5% and in 43%4 where two or more parathyroid glands were hyperplastic or adenomatous (Boey et al., 1975) . In another series MEA was present in 18% of cases with chief cell hyperplasia (Castleman, Schantz and Roth, 1976) .
In a recent study of the relatives of 100 consecutive patients with tumours or hyperplasia of the parathyroids, involvement of at least one additional family member was observed in ten index cases in the 91 of whom family data could be obtained (11%). MEA Type I was found in three families and MEA Type II in two families (Jackson, Frome and Block, 1977) .
Cases with features of both MEA Type I and Type II have been reported recently (Hansen et al., 1976) . Patient II3 in the present series showed a raised calcitonin (3*8 [Lg/l) but as no medullary thyroid carcinoma was found this was probably secondary to the raised gastrin (Sizemore et al., 1973) . The patient's nephew, III2, also had a slightly raised calcitonin (0-32 ,ug/l) with a raised serum parathyroid hormone and calcium but normal gastrin. A pentagastrin-calcitonin stimulation test did not suggest medullary thyroid carcinoma, and the raised calcitonin might have been due to the raised calcium or parathyroid hormone (Sizemore and Go, 1975; Tashjian et al., 1970) .
This case study emphasizes the importance of family surveillance and long-term follow-up in primary hyperparathyroidism. The authors suggest that all first degree relatives of patients with primary hyperparathyroidism, particularly when it is due to chief cell hyperplasia, should have a full clinical assessment and serum calcium and phosphate estimations. Further follow-up may be necessary in 
